TMPRSS2 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 220 results for "TMPRSS2"
i
  1. TMPRSS2 Influences Prostate Cancer Metastasis BioProject

    ID: PRJNA253587

    Keywords: Transcriptome or Gene expression

    Access Type: download

  2. TMPRSS2 Influences Prostate Cancer Metastasis ArrayExpress

    ID: E-GEOD-58822

    Description: TMPRSS2 is an androgen-regulated cell surface serine protease expressed predominantly in prostate epithelium. TMPRSS2

  3. Influenza A virus H3N2 : TMPRSS2-Independent Activation of H3N2 Influenza Virus BioProject

    ID: PRJDB2982

    Keywords: Transcriptome or Gene expression

    Access Type: download

  4. TMPRSS2 Influences Prostate Cancer Metastasis OmicsDI

    ID: E-GEOD-58822

    Date Released: 09-15-2014

    Description: TMPRSS2 is an androgen-regulated cell surface serine protease expressed predominantly in prostate epithelium. TMPRSS2

  5. Radical prostatectomy specimens with and without TMPRSS2:ERG fusion from 139 patients with prostate in a Toronto cohort BioProject

    ID: PRJNA121595

    Keywords: Transcriptome or Gene expression

    Access Type: download

  6. Investigating gene expression changes in wildtype and TMPRSS2-ERG homozygous mouse prostate tissue BioProject

    ID: PRJNA260065

    Keywords: Transcriptome or Gene expression

    Access Type: download

  7. TMPRSS2-ERG fusion prostate cancer is a molecularly distinct estrogen-sensitive subclass of aggressive prostate cancer BioProject

    ID: PRJNA101455

    Keywords: Transcriptome or Gene expression

    Access Type: download

  8. Mus musculus : Transcriptome analysis in TMPRSS2 KO mice. BioProject

    ID: PRJDB2553

    Keywords: Other

    Access Type: download

  9. TMPRSS2-ERG fusion prostate cancer is a molecularly distinct estrogen-sensitive subclass of aggressive prostate cancer ArrayExpress

    ID: E-GEOD-8402

    Description: the 5'-untranslated region of androgen regulated TMPRSS2 promoter with ETS transcription factor family members has brought this paradigm into question1,2. TMPRSS2-ERG gene fusion is the most common molecular sub-type of prostate cancer. Recent work suggests that the TMPRSS2-ERG fusion is associated with a more aggressive clinical phenotype3. In the most advanced castration resistant prostate cancers wh...

  10. TMPRSS2-ERG fusion prostate cancer is a molecularly distinct estrogen-sensitive subclass of aggressive prostate cancer OmicsDI

    ID: E-GEOD-8402

    Date Released: 05-02-2014

    Description: the 5'-untranslated region of androgen regulated TMPRSS2 promoter with ETS transcription factor family members has brought this paradigm into question1,2. TMPRSS2-ERG gene fusion is the most common molecular sub-type of prostate cancer. Recent work suggests that the TMPRSS2-ERG fusion is associated with a more aggressive clinical phenotype3. In the most advanced castration resistant prostate cancers wh...

  11. Radical prostatectomy specimens with and without TMPRSS2:ERG fusion from 139 patients with prostate in a Toronto cohort ArrayExpress

    ID: E-GEOD-18655

    Description: Prostate tumors with the gene fusion TMPRSS2:ERG have been reported to have a significantly higher risk of recurrence compared with tumors lacking the fusion. Tumors fr...

  12. TMPRSS2-ERG, HDACs and EZH2 are involved in an AR-centric transcriptional circuitry that calibrates androgenic response for prostat... ArrayExpress

    ID: E-GEOD-28951

    Description: omposed of the following subset Series: GSE28948: TMPRSS2-ERG, HDACs and EZH2 are involved in an AR-centric transcriptional circuitry that calibrates androgenic response for prostate cancer progression ...

  13. Investigating gene expression changes in wildtype and TMPRSS2-ERG homozygous mouse prostate tissue ArrayExpress

    ID: E-GEOD-61008

    Description: A transgenic TMPRSS2:ERG mouse model was engineered in FVB background and compared to its wildtype counterpart in the absence of any treatment ...

  14. IGR_JUNCONCO_STUDY_LM OmicsDI

    ID: E-MTAB-2838

    Date Released: 08-13-2014

    Description: Antineoplastic effects of siRNA against TMPRSS2-ERG junction oncogene in prostate cancer: from molecular and cellular studies to preclinical investigations. Background of ...

  15. Radical prostatectomy specimens with and without TMPRSS2:ERG fusion from 139 patients with prostate in a Toronto cohort OmicsDI

    ID: E-GEOD-18655

    Date Released: 06-27-2012

    Description: Prostate tumors with the gene fusion TMPRSS2:ERG have been reported to have a significantly higher risk of recurrence compared with tumors lacking the fusion. Tumors fr...

  16. Investigating gene expression changes in wildtype and TMPRSS2-ERG homozygous mouse prostate tissue OmicsDI

    ID: E-GEOD-61008

    Date Released: 09-06-2014

    Description: A transgenic TMPRSS2:ERG mouse model was engineered in FVB background and compared to its wildtype counterpart in the absence of any treatment ...

  17. Homo sapiens : Homo sapiens Targeted Locus (Loci) BioProject

    ID: PRJNA160005

    Keywords: targeted loci

    Access Type: download

    dataset.description: TMPRSS2-ERG translocations occur in approximately 50% of prostate cancers and therefore represent one of the most frequently observ...
  18. TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells BioProject

    ID: PRJNA312383

    Keywords: Transcriptome or Gene expression

    Access Type: download

  19. TMPRSS2-ERG, HDACs and EZH2 are involved in an AR-centric transcriptional circuitry that calibrates androgenic response for prostat... OmicsDI

    ID: E-GEOD-28951

    Date Released: 06-02-2014

    Description: omposed of the following subset Series: GSE28948: TMPRSS2-ERG, HDACs and EZH2 are involved in an AR-centric transcriptional circuitry that calibrates androgenic response for prostate cancer progression ...

  20. IGR_JUNCONCO_STUDY_LM ArrayExpress

    ID: E-MTAB-2838

    Description: Antineoplastic effects of siRNA against TMPRSS2-ERG junction oncogene in prostate cancer: from molecular and cellular studies to preclinical investigations. Background of ...


Displaying 20 of 220 results for "TMPRSS2"